title: Announcing a TAFIa mutant with a 180-fold increased half-life and concomitantly a strongly increased antifibrinolytic potential.
authors.forename: E
authors.initials: E
authors.lastname: Ceresa
authors.forename: M
authors.initials: M
authors.lastname: Peeters
authors.forename: P J
authors.initials: PJ
authors.lastname: Declerck
authors.forename: A
authors.initials: A
authors.lastname: Gils
mesh_terms: D025901:Carboxypeptidase B2 / Q000737:chemistry / Q000235:genetics*; D005342:Fibrinolysis; D006207:Half-Life; D006487:Hemostasis; D006801:Humans; D009154:Mutation
chemical_list: D025901:Carboxypeptidase B2